Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study
Open Access
- 4 March 2010
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 105 (7), 956-962
- https://doi.org/10.1111/j.1464-410x.2009.08887.x
Abstract
Study Type – Therapy (prospective cohort)Level of Evidence 2b OBJECTIVE To evaluate the short‐term outcomes of the prospective international Prostate Cancer Research International: Active Surveillance (‘PRIAS’) study (Dutch Trial Register NTR1718), as active surveillance (AS) for early prostate cancer might provide a partial solution to the current overtreatment dilemma in this disease. PATIENTS AND METHODS The first 500 (of >950) participants with asymptomatic T1c/T2 prostate cancer, with a prostate‐specific antigen (PSA) level of ≤10.0 ng/mL, a PSA density of 6 or more than two positive biopsy cores. There was a relatively unfavourable PSA doubling time of 0–10 years in 53% (102/194) and 62% (33/53) of men with favourable and unfavourable re‐biopsy results, respectively. After RP, four of 24 (17%) men had T3 disease and 12 (50%) had a Gleason score of >6. CONCLUSION AS seems feasible, but mortality outcomes are unknown. A strict follow‐up protocol including standard 1‐year repeat biopsies resulted in a quarter of men stopping AS after 2 years.Keywords
This publication has 27 references indexed in Scilit:
- Pathological Outcomes of Candidates for Active Surveillance of Prostate CancerJournal of Urology, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009
- Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized TrialJNCI Journal of the National Cancer Institute, 2008
- Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillanceCancer, 2008
- The Relationship Between Anxiety and Time to Treatment for Patients With Prostate Cancer on SurveillanceJournal of Urology, 2007
- Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experienceBJU International, 2007
- How much does Gleason grade of follow‐up biopsy differ from that of initial biopsy in untreated, Gleason score 4–7, clinically localized prostate cancer?The Prostate, 2007
- Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptanceBJU International, 2007
- The story of the European Randomized Study of Screening for Prostate CancerBJU International, 2003
- A MODEL FOR THE NUMBER OF CORES PER PROSTATE BIOPSY BASED ON PATIENT AGE AND PROSTATE GLAND VOLUMEJournal of Urology, 1998